Company profile for Aquavit Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We focus on personalized medicine to improve our patients’ health, maximize the efficiency of our medical community, and support the pharmacoeconomics of our payers. This strategic focus is aligned with our modernized and diversified approaches. It is this combination that enables our research and development to address unmet needs. Science personalized. Healthcare modernized.Aquavit Pharmaceuticals, Inc. is committed to pr...
We focus on personalized medicine to improve our patients’ health, maximize the efficiency of our medical community, and support the pharmacoeconomics of our payers. This strategic focus is aligned with our modernized and diversified approaches. It is this combination that enables our research and development to address unmet needs. Science personalized. Healthcare modernized.Aquavit Pharmaceuticals, Inc. is committed to providing a variety of quality merchandise for customers. By using the latest technologies and applying strict quality control procedures, we’ve become known for having the best products in the industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
145 W 57TH ST New York, NY 10019
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Aquavit files IND for Dermatox Phase II/III study
Aquavit files IND for Dermatox Phase II/III study

01 May 2023

// CIINICAL TRIALS ARENA

https://www.clinicaltrialsarena.com/news/aquavit-ind-for-dermatox/

CIINICAL TRIALS ARENA
01 May 2023

https://www.prnewswire.com/news-releases/aquavit-files-investigational-new-drug-application-for-its-flagship-intradermal-injection-of-botulinum-toxin-301811089.html

PR NEWSWIRE
28 Apr 2023

https://www.prnewswire.com/news-releases/aquavit-files-two-inds-for-its-botulinum-toxin-with-fda-301775386.html

PR NEWSWIRE
17 Mar 2023

https://www.prnewswire.com/news-releases/aquavit-files-ind-with-fda-for-dtx-021-a-new-botulinum-toxin-301510523.html

PRNEWSWIRE
24 Mar 2022

https://www.prnewswire.com/news-releases/aquavit-further-prevails-against-counterfeiters-in-us-following-its-recent-victory-in-europe-301506975.html

PRNEWSWIRE
21 Mar 2022

https://www.prnewswire.com/news-releases/aquavits-aqv-1122-covid-19-vaccine-patent-approval-fast-tracked-by-uspto-301367576.html

PRNEWSWIRE
01 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty